Signal transduction in vasculogenesis and developmental angiogenesis

International Journal of Developmental Biology

Volumn 55, Issue 4-5, 2011, Pages 353-369

  Patel Hett, Sunita ^a   D'Amore, Patricia A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Blood vessel formation; Endothelium; Vascular development; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN; EPHRIN; EPHRIN RECEPTOR; FIBROBLAST GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR; NETRIN; NEUROPILIN; NOTCH RECEPTOR; PLATELET DERIVED GROWTH FACTOR; ROUNDABOUT RECEPTOR; SEMAPHORIN; SLIT PROTEIN; SONIC HEDGEHOG PROTEIN; SPROUTY PROTEIN; TIE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTERY; ARTICLE; CELL FATE; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; HUMAN; HYPOXIA; MATURATION; MOLECULAR MECHANICS; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; VASCULARIZATION; VEIN;

ANIMALS; ANOXIA; BLOOD VESSELS; EPHRINS; FIBROBLAST GROWTH FACTORS; HEDGEHOG PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPILINS; RECEPTORS, NOTCH; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SEMAPHORINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960981005     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.103213sp     Document Type: Article

References (146)

1. AASE, K., VON EULER, G., LI, X., PONTEN, A., THOREN, P., CAO, R., CAO, Y., OLOFSSON, B., GEBRE-MEDHIN, S., PEKNY, M. et al. (2001). Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect. Circulation 104: 358-364.
2. AHMED, Z. and BICKNELL, R. (2009). Angiogenic signalling pathways. Methods Mol Biol. 467: 3-24.
3. ASAHARA, T., MUROHARA, T., SULLIVAN, A., SILVER, M., VAN DER ZEE, R., LI, T., WITZENBICHLER, B., SCHATTEMAN, G. and ISNER, J.M. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
4. AZUMA, H. (2000). Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia. J Med Invest. 47: 81-90.
5. BAIRD, A. and DURKIN, T. (1986). Inhibition of endothelial cell proliferation by type beta-transforming growth factor: interations with acidic and basic fibroblast growth factors. Biochem. Biophys. Res. Commun. 138: 476-482.
6. BANU, N., TEICHMAN, J., DUNLAP-BROWN, M., VILLEGAS, G.A.T. (2006). Semaphorin 3C regulates endothelial cell function by increasing integrin activity. FASEB J. 20: 2150-2152.
7. BARBARA, N.P., WRANA, J.L. and LETARTE, M. (1999). Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem. 274: 584-594.
8. BATES, D.O., CUI, T.G., DOUGHTY, J.M., WINKLER, M., SUGIONO, M., SHIELDS, J.D., PEAT, D., GILLATT, D. and HARPER, S.J. (2002). VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62.
9. BEDELL, V.M., YEO, S.Y., PARK, K.W., CHUNG, J., SETH, P., SHIVALINGAPPA, V., ZHAO, J., OBARA, T., SUKHATME, V.P., DRUMMOND, I.A. et al. (2005). Roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci USA 102: 6373-6378.
10. BEENKEN, A. and MOHAMMADI, M. (2009). The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov. 8: 235-253.
11. BELLOMO, D., HEADRICK, J.P., SILINS, G.U., PATERSON, C.A., THOMAS, P.S., GARTSIDE, M., MOULD, A., CAHILL, M.M., TONKS, I.D., GRIMMOND, S.M. et al. (2000). Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischaemia. Circ Res. 86: E29-E35.
12. BENEDITO, R., ROCA, C., SORENSEN, I., ADAMS, S., GOSSLER, A., FRUTTIGER, M. and ADAMS, R.H. (2009). The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137: 1124-1135.
13. BIELENBERG, D.R., HIDA, Y., SHIMIZU, A., KAIPAINEN, A., KREUTER, M., KIM, C.C. and KLAGSBRUN, M. (2004). Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest. 114: 1260-1271.
14. BRAMBILLA, E., CONSTANTIN, B., DRABKIN, H. and ROCHE, J. (2000). Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration. Am J Pathol. 156: 939-950.
15. BYRD, N., BECKER, S., MAYE, P., NARASIMHAIAH, R., ST-JACQUES, B., ZHANG, X., MCMAHON, J., MCMAHON, A.P. and GRABEL, L. (2002). Hedgehog is required for murine yolk sac angiogeneis. Development 129: 361-372.
16. CABRITA, M.A. and CHRISTOFORI, G. (2008). Sprouty proteins, masterminds of receptor tyrosine kinase signaling. Angiogenesis 11: 53-62.
17. CAO, Y., LINDEN, R., FARNEBO, J., CAO, R., ERIKSSON, A., KUMAR, V., QI, J.H., CLAESSON-WELSH, L. and ALITALO, K. (1998). Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 95: 14389-14394.
18. CAPPARUCCIA, L. and TAMAGNONE, L. (2009). Semaphorin signaling in cancer cells and in cells of the tumor microenvironment-two sides of a coin. J Cell Sci 122: 1723-1736.
19. CAPRIOLI, A., MINKO, K., DREVON, C., EICHMANN, A., DIETERLEN-LIEVRE, F. and JAFFREDO, T. (2001). Hemangioblast commitment in the avian allantois: cellular and molecular aspects. Dev Biol 238: 64-78.
20. CARMELIET, P., FERREIRA, V., BREIER, G., POLLEFEYT, S., KIECKENS, L., GERTSENSTEIN, M., FAHRIG, M., VANDENHOECK, A., HARPALL, K., EBERHARDT, C. et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439.
21. CARMELIET, P., MOONS, L., LUTTUN, A., VINCENTI, V., COMPERNOLLE, V., DE MOL, M., WU, Y., BONO, F., DEVY, L., BECK, H. et al. (2001). Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7: 575-583.
22. CHEN, H., BAGRI, A., ZUPICICH, J., ZOU, Y., STOECKLI, E., PLEASURE, S., LOWENSTEIN, D., SKARNES, W., CHEDOTAL, A. and TESSIER-LAVIGNE, M. (2000). Neuropilin-2 regulates the development of select cranial and sensory nerves and hippocampal mossy fiber projections. Neuron 25: 43-56.
23. CHEN, Y.G., HATA, A., LO, R.S., WOTTON, D., SHI, Y., PAVIETICH, M. and MASSAGUE, J. (1998). Determinants of specificity in TGF-beta signal transduction. Genes Dev. 12: 2144-2152.
24. CHOI, K., KENNEDY, M., KAZAROV, A., PAPADIMITRIOU, J.C. and KELLER, G. (1998). A common precursor for hematopoietic and endothelial cells. Development 125: 725-732.
25. COX, C.M. and POOLE, T.J. (2000). Angioblast differentiation is influenced by thelocal environment: FGF-2 induces angioblasts and patterns vessel formation in the quail embryo. Dev Dyn 18: 371-382.
26. DAVIS, S., ALDRICH, T.H., JONES, P.F., ACHESON, A., COMPTON, D., JAIN, V., RYAN, T.E., BRUNO, J., RADZIEJEWSKI, C., MAISONPIERRE, P.C. et al. (1996). Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87: 1161-1169.
27. DAYANIR, V., MEYER, R.D., LASHKARI, K. and RAHIMI, N. (2001). Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J Biol Chem 276: 17686-17692.
28. DETMAR, M., BROWN, L.F., SCHON, M.P., ELICKER, B.M., VELASCO, B., RICHARD, L., FUKUMURA, D., MONSKY, W., CLAFFEY, K.P. and JAIN, R.K. (1998). Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol. 111: 1-6.
29. DICKSON, M.C., MARTIN, J.S., COUSINS, F.M., KULKARNI, A.B., KARLSSON, S. and AKHURST, R.J. (1995). Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121: 1845-1854.
30. DJONOV, V., KURZ, H. and BURRI, P.H. (2002). Optimality in the developing vascular system: branching remodeling by means of intussusception as an effective adaptation mechanism. Dev Dyn 224: 391-402.
31. DJONOV, V., SCHMID, M., TSCHANZ, S.A. and BURRI, P.H. (2000). Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ Res. 86: 286-292.
32. DUMONT, D.J., GRADWOHL, G., FONG, G.H., PURI, M.C., GERTSENSTEIN, M., AUERBACH, A. and BREITMAN, M.L. (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8: 1897-1909.
33. DYER, M.A., FARRINGTON, S.M., MOHN, D., MUNDAY, J.R. and BARON, M.H. (2001). Indian hedgehog activated hematopoiesis and vasculogenesis and can rectify neurectodermal cell fate in the mouse embryo. Development 128: 1717-30.
34. EICHMANN, A., CORBEL, C., NATAF, V., VAIGOT, P., BREANT, C. and LE DOUARIN, N.M. (1997). Ligand-dependent development of the endothelial and hemopoietic linages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc Natl Acad Sci USA 94: 5141-5416.
35. FERRARA, N., CARVER-MOORE, K., CHEN, H., DOWD, M., LU, L., O'shea, K.S. POWELL-BRAXTON HILLAN K.J. and MOORE M.W (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442.
36. FOLKMAN, J. (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-6.
37. FONG, G.H., ROSSANT, J., GERTSENSTEIN, M. and BREITMAN, M.L. (1995). Role of the Flit-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70.
38. FRATER-SCHRODER, M., MULLER, G. and BIRCHMEIER, W. (1986). Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem. Biophys. Res. Commun. 137: 295-302.
39. FUJIO, Y. and WALSH, K. (1999). Akt mediate cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 274: 16349-16354.
40. FUKUMURA, D., GOHONGI, T., KADAMBI, A., IZUMI, Y., ANG, J., YUN, C.O., BUERK, D.G., HUANG, P.L. and JAIN, R.K. (2001). Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98: 2604-2609.
41. GAUR, P., BIELENBERG, D.R., SAMUEL, S., BOSE, D., ZHOU, Y., GRAY, M.J., DALLAS, N.A., FAN, F., XIA, L., LU, J. et al. (2009). Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. Clin Cancer Res 15: 6763-6770.
42. GAVARD, J. and GUTKIND, J.S. (2006). VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 8: 1223-1234.
43. GERETY, S.S., WANG, H.U., CHEN, Z.F. and ANDERSON, D.J. (1999). Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell. 4: 403-414.
44. GERHARDT, D., GOLDING, M., FRUTTIGER, M., RUHRBERG, C., LUNDKVIST, A., AMBRAMSSON, A., JELTSCH, M., MITCHELL, C., ALITALO, K., SHIMA, D. et al. (2003). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161: 1163-1177.
45. GIGER, R.J., CLOUTIER, J.F., SAHAY, A., PRINJHA, R.K., LEVENGOOD, D.V., MOORE, S.E., PICKERING, S., SIMMONS, D., RASTAN, S., WALSH, F.S. et al. (2000). Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron 25: 29-41.
46. GOUMANS, M.J. and MUMMERY, C. (2000). Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44: 253-265.
47. GU, C., YOSHIDA, Y., LIVET, J., REIMERT, D.V., MANN, F., MERTE, J., HENDERSON, C.E., JESSELL, T.M., KOLODKIN, A.L. and GINTY, D.D. (2005). Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307: 265-268.
48. GUTTMANN-RAVIV N, S.-H.N., VARSHAVSKY A., GUIMARAES-STERNBERG C, KESSLER O, NEUFELD G. (2007). Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem. 282: 26294-26305.
49. HELLSTROM, M., GERHARDT, H., KALEN, M., LI, X., ERIKSSON, U. and WOLBURH, H. (2001). Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153: 543-553.
50. HELLSTROM, M., KALEN, M., LINDAHL, P., ABRAMSON, A. and BETSCHOLTZ, C. (1999). Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126: 3047-3055.
51. HERZOG, Y., GUTTMANN-RAVIV, N. and NEUFELD, G. (2005). Segregation of arterial and venous markers in subpopulations of blood islands before vessel formation. Dev Dyn. 232: 1047-1055.
52. HIRASHIMA, M. (2009). Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling. Anat Sci Int. 84: 95-101.
53. HIS, W. (1900). Lecithoblast und Angioblast der Wirbelthiere. Abhandl. K.S. Ges. Wis. Math.-Phys. 22: 171-328.
54. HOFER, E. and SCHWEIGHOFER, B. (2007). Signal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis. Thromb Haemost. 97: 355-63.
55. HOLASH, J., WEIGAND, S.J. and YANCOPOULOS, G.D. (1999). New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18: 5356-62.
56. HOLMQVIST, K., CROSS, M.J., ROLNEY, C., HAGERKVIST, R., RAHIMI, N., MATSUMOTO, T., CLAESSON-WELSH, L. and WELSH, M. (2004). The adaptor protein shb bind to tyrosine 1175 in vacular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J Biol Chem 279: 22267-22275.
57. HOODLESS, P.A. and WRANA, J.L. (1998). Mechanism and function of signaling by the TGF beta superfamily. Curr. Top. Microbiol. Immunol. 228: 235-272.
58. HRABE DE ANGELIS, M., MCINTYRE, J.N. and GOSSLER, A. (1997). Maintenance of somite borders in mice requires the Delta homologue DII1. Nature 717-21.
59. HUMINIECKI, L. and BICKNELL, R. (2000). In silico cloning of novel endothelial-specific genes. Genome Res. 10: 1796-1806.
60. IMPAGNATIELLO MA, W.S., GANNON G, COMPAGNI A, COTTEN M, CHRISTOFORI G. (2001). Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J Cell Biol. 152: 1087-1098.
61. IRUELA-ARISPE, M.L. and SAGE, E.H. (1993). Endothelial cells exhibiting engiogenesis in vitro proliferate in response to TGF-beta. J. Cell. Biochem. 52: 414-430.
62. IVAN, M., KONDO, K., YANGE, H., KIM, W., VALIANDO, J., OHH, M., SALIC, A., ASARA, J.M., LANE, W.S. and KAELIN, W.G.J. (2001). HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292: 464-468.
63. IYER, N.V., KOTCH, L.E., AGANI, F., LEUNG, S.W., LAUGHNER, E., WENGER, R.H., GASSMANN, M., GEARHART, J.D., LAWLER, A.M., YU, A.Y. et al. (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12: 149-162.
64. JAAKKOLA, P., MOLE, D.R., TIAN, Y.M., WILSON, M.I., GIELBERT, J., GASKELL, S.J., KRIEGSHEIM, A.V., HEBESTREIT, H.F., MUKERJI, M., SCHOFIELD, C.J. et al. (2001). Targeting of HIFalpha to the von Hipple-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 929: 468-472.
65. JAKOBSSON, L., BENTLEY, K. and GERHARDT, H. (2009). VEGFRs and Notch: a dynamic collaboration in vascular patterning. Biochem. Soc. Trans. 37: 1233-1236.
66. JENKINS, D. (2009). Hedgehog signalling: emerging evidence for non-canonical pathways. Cell Signal. 21: 1023-1034.
67. KARAMYSHEVA, A.F. (2008). Mechanisms of angiogenesis. Biochemistry (Mosc) 73: 751-762.
68. KARKKAINEN, M.J., HAIKO, P., SAINIO, K., PARTANEN, J., TAIPALE, J., PETROVA, T.V., JELTSCH, M., JACKSON, D.G., TALIKKA, M., RAUVALA, H. et al. (2003). Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nature Immunology 5: 74-80.
69. KAWASAKI, T., KITSUKAWA, T., BEKKU, Y., MATSUDA, Y., SANBO, M., YAGI, T. and FUJISAWA, H. (1999). A requirement for neuropilin-1 in embryonic vessel formation. Development 126: 4895-4902.
70. KELLY, B.D., HACKETT, S.F., HIROTA, K., OSHIMA, Y., CAI, Z., BERG-DIXON, S., ROWAN, A., YAN, Z., CAMPOCHIARO, P.A. and SEMENZA, G.L. (2003). Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res. 93: 1074-1081.
71. KENDALL, R.L., RUTLEDGE, R.Z., MAO, X., TEBBEN, A.J., HUNGATE, R.W. and THOMAS, K.A. (1999). Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues. J Biol Chem. 274: 6453-6460.
72. KESSLER, O., SHRAGA-HELED, N., LANGE, T., GUTMANN-RAVIV, N., SABO, E., BARUCH, L., MACHLUF, M. and NEUFELD, G. (2004). Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res 64: 1008-1015.
73. KEYT, B.A., BERLEAU, L.T., NGUYEN, H.V., CHEN, H., HEINSOHN, H., VANDLEN, R. and FERRARA, N. (1996). The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem. 271: 7788-7795.
74. KIGEL, B., VARSHAVSKY, A., KESSLER, O. and NEUFELD, G. (2008). Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells. PLos One. 3: e3287.
75. KOWANETZ, M. and FERRARA, N. (2006). Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 12: 5018-5022.
76. KREBS, L.T. (2000). Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 14: 1343-1352.
77. KREBS, L.T., SHUTTER, J.R., TANIGAKI, K., HONJO, T., STARK, K.L. and GRIDLEY, T. (2004). Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev 18: 2469-2473.
78. LAMALICE, L., HOULE, F., JOURDAN, G. and HUOT, J. (2004). Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Oncogene 23: 434-445.
79. LARSSON, J., GOUMANS, M.J., SJOSTRAND, L.J., VAN ROOIJEN, M.A., WARD, D., LEVEEN, P., XU, X., TEN DIJKE, P., MUMMERY, C.L. and KARLSSON, S. (2001). Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 20: 1663-1673.
80. LECOUTER, J., KOWALSKI, J., FOSTER, J., HASS, P., ZHANG, Z., DILLARD-TELM, L., FRANTZ, G., RANGELL, L., DEGUZMAN, L., KELLER, G.A. et al. (2001). Identification of an angiogenic mi-togen selective for endocrine gland endothelium. Nature 412: 877-884.
81. LETAMENDIA, A., LASTRES, P., BOTELLA, L.M., RAAB, U., LANGA, C., VELASCO, B., ATTISANO, L. and BERNABEU, C. (1998). Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. J Biol Chem. 273: 33011-33019.
82. LETTERIO, J.J., GEISER, A.G., KULKARNI, A.B., ROCHE, N.S., SPORN, M.B. and ROBERTS, A.B. (1994). Maternal rescue of transforming growth factor-beta 1 null mice. Science 264: 1936-1938.
83. LI, C., GUO, B., BERNABEU, C. and KUMAR, S. (2001). Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105. Microsc. Res. Tech. 52: 437-449.
84. LI, D.Y., SORENSEN, L.K., BROOKE, B.S., URNESS, L.D., DAVIS, E.C., TAYLOR, D.G., BOAK, B.B. and WENDEL, D.P. (1999). Defective angiogenesis in mice lacking endoglin. Science 284: 1534-1537.
85. LIU, Z., SHIRAKAWA, T., LI, Y., SOMA, A., OKA, M., DOTTO, G.P., FAIRMAN, R.M., VELAZQUEZ, O.C. and HERLYN, M. (2003). Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol 23: 12-25.
86. LOBOV, I.B., RENARD, R.A., PAPADOPOULOS, N., GALE, N.W., THURSTON, G., YANCOPOULOS, G.D. and WIEGAND, S.J. (2007). Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA 104: 3219-3224.
87. LU, X., LE NOBLE, F., YUAN, L., JIANG, Q., DE LAFARGE, B., SUGIYAMA, D., BRÉANT, C., CLAES, F., DE SMET, F., THOMAS, J.L. et al. (2004). The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature 432: 179-186.
88. LYTTLE, D.J., FRASER, K.M., FLEMING, S.B., MERCER, A.A. and ROBINSON, A.J. (1994). Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J. Virol. 68: 84-92.
89. MAGLIONE, D., GUERRIERO, V., VIGLIETTO, G., DELLI-BOVI, P. and PERISCO, M.G. (1991). Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88: 9267-9271.
90. MAISONPIERRE, P.C., SURI, C., JONES, P.F., BARTUNKOVA, S., WEIGAND, S.J., RADZIEJEWSKI, C., COMPTON, D., MCCLAIN, J., ALDRICH, T.H., PAPADOPOULOS, N. et al. (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60.
91. MAKANYA, A.N., HLUSHCHUK, R. and DJONOV, V. (2009). Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling. Angiogenesis 12: 113-123.
92. MATSUMOTO, T., BOHMAN, S., DIXELIUS, J., BERGE, T., DIMBERG, A., MAGNUSSON, P., WANG, L., WIKNER, C., QI, J.H., WERNSTEDT, C. et al. (2005). VEGF receptor-s Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J. 24: 2342-2353.
93. MECHTCHERIAKOVA, D., SCHABBAUER, G., LUCERNA, M., CLAUSS, M., DE MARTIN, R., BINDER, B.R. and HOFER, E. (2001). Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. FASEB J. 15: 230-424.
94. MECHTCHERIAKOVA, D., WLACHOS, A., HOLZMULLER, H., BINDER, B.R. and HOFER, E. (1999). Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. Blood 93: 3811-3823.
95. MIAO, H.Q., SOKER, S., FEINER, L., ALONSO, J.L., RAPER, J.A. and KLAGSBRUN, M. (1999). Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 146: 233-242.
96. NAGASE, M., NAGASE, T., KOSHIMA, I. and FUJITA, T. (2006). Critical time window of hedgehog-dependent angiogenesis in murine yolk sac. Microvasc Res 71: 85-90.
97. OLSSON, A.K., DIMBERG, A., KREUGER, J. and CLAESSON-WELSH, L. (2006). VEGF receptor signaling in control of vascular function. Nat Rev Mol Cell Biol 7: 359-371.
98. OSHIMA, M., OSHIMA, H. and TAKETO, M.M. (1996). TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 179: 297-302.
99. PARDANAUD, L. and DIETERLEN-LIEVRE, F. (1993). Emergence of endothelial and hemopoietic cells in the avian embryo. Anat Embryol (Berl) 187: 107-114.
100. PARK, K.W., CROUSE, D., LEE, M., KARNIK, S.K., SORENSEN, L.K., MURPHY, K.J., KUO, C.J. and LI, D.Y. (2004). The axonal attractant Netrin-1 is an angiogenic factor. Proc Natl Acad Sci USA 101: 16210-16215.
101. PARK, K.W., MORRISON, C.M., SORENSEN, L.K., JONES, C.A., RAO, Y., CHIEN, C.B., WU, J.Y., URNESS, L.D. and LI, D.Y. (2003). Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev Biol. 261: 251-267.
102. PATAN, S. (2000). Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J. Neuroloncol 50: 1-15.
103. PEET, D. and LINKE, S. (2006). Regulation of HIF: Asparaginyl hydroxylation. Novartis Found Symp 272: 37-49.
104. RAMIREZ-BERGERON, D.L., RUNGE, A., ADELMAN, D.M., GOHIL, M. and SIMON, M.C. (2006). HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature. Dev Cell 11: 81-92.
105. RAYCHAUDHURY, A. and D'amore, P.A. (1991). Endothelial cell regulation by transforming growth factor-beta. J. Cell. Biochem. 47: 224-229.
106. REAGAN, F.P. (1915). Vascularization phenomena in fragments of embryonic bodies completely isolated from yolk sac blastoderm. Anat Rec. 9: 329-341.
107. RIBATTI, D., NICO, B. and CRIVELLATO, E. (2009). Morphological and molecular aspects of physiological vascular morphogenesis. Angiogenesis 12: 101-111.
108. RIOBO, N.A., SAUCY, B., DILIZIO, C. and MANNING, D.R. (2006). Activation of heterotrimeric G proteins by Smoothened. Proc Natl Acad Sci USA 103: 12607-12612.
109. RISAU, W. and FLAMME, I. (1995). Vasculogenesis. Annu Rev Cell Dev Biol 11: 74-91.
110. RISAU, W. and LEMMON, V. (1988). Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol 125: 441-450.
111. RISAU, W., SARIOLA, H., ZERWES, H.G., SASSE, J., EKBLOM, P., KEMLER, R. and DOETSCHMAN, T. (1988). Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 102: 471-478.
112. ROBERTS, A.B., SPORN, M.B., ASSOIAN, R.K., SMITH, J.M., ROCHE, N.S., WAKEFIELD, L.M., HEINE, U.I., LIOTTA, L.A., FALANGA, V., KEHRL, J.H. et al. (1986). Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167-471.
113. ROCHE, J., BOLDOG, F., ROBINSON, M., ROBINSON, L., VARELLA-GARCIA, M., SWANTON, M., WAGGONER, B., FISHEL, R., FRANKLIN, W., GEMMILL, R. et al. (1996). Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene 12: 1289-1297.
114. ROSSANT, J. and HOWARD, L. (2002). Signaling pathways in vascular development. Annu. Rev. Cell Dev. Biol. 18: 541-573.
115. SABIN, F.R. (1920). Studies on the origin of blood-vessels and of red blood-corpuscles as seen in the living blastoderm of chicks during the second day of incubation. Contrib Embryol 36: 213-259.
116. SALCEDA, S. and CARO, J. (1997). Hypoxia-inducible factor 1 alpha (HIF1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem. 272: 22642-22647.
117. SASAKI, A., TAKETOMI, T., KATO, R., SAEKI, K., NONAMI, A., SASAKI, M., KURIYAMA, M., SAITO, N., SHIBUYA, M. and YOSHIMURA, A. (2003). Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat Cell Biol. 5: 427-432.
118. SATO, T.N., TOZAWA, Y., DEUTSCH, U., WOLBURG-BUCHHOLZ, K., FUJIWARA, Y., GENDRON-MAGUIRE, M., GRIDLEY, T., WOLBURG, H., RISAU, W. and QIN, Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74.
119. SEMENZA, G.L. (2007). Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem. 102: 840-847.
120. SENGER, D.R., CONNOLLY, D.T., VAN DE WATER, L., FEDER, J. and DVORAK, H.F. (1990). Purification and NH2-terminal amino acid sequece of guinea pig tumor-secreted vascular permeability factor. Cancer Res 15: 1774-1778.
121. SHALABY, F., HO, J., STANFORD, W.L., FISCHER, K.D., SCHUH, A.C., SCHWARZ, L., BERNSTEIN, A. and ROSSANT, J. (1997). A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89: 981-990.
122. SHALABY, F., ROSSANT, J., YAMAGUCHI, T.P., GERTSENSTEIN, M., WU, X.F., BREITMAN, M.L. and SCHUH, A.C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.
123. SHAWBER, C.J., DAS, I., FRANCISCO, E. and KITAJEWSKI, J. (2003). Notch signaling in primary endothelial cells. Ann NY Acad Sci 995: 162-170.
124. SPRINGER, M.L., CHEN, A.S., KRAFT, P.E., BEDNARSKI, M. and BLAU, H.M. (1998). VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 2: 549-558.
125. SUCHTING, S., FREITAS, C., LE NOBLE, F., BENEDITO, R., BREANT, C., DUARTE, A. and EICHMANN, A. (2007). The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA 104: 3225-3230.
126. SUCHTING, S., HEAL, P., TAHTIS, K., STEWART, L.M. and BICKNELL, R. (2005). Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration. FASEB J. 19: 121-123.
127. SURI, C., JONES, P.F., PATAN, S., BARTUNKOVA, S., MAISONPIERRE, P.C., DAVIS, S., SATO, T.N. and YANCOPOULOS, G.D. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 1171-1180.
128. SUTTON, A.B., CANFIELD, A.E., SCHOR, S.L., GRANT, M.A. and SCHOR, A.M. (1991). The response of endothelial cells to TGF-beta-1 is dependent upon cell shape, proliferative state and the nature of the substratum. J Cell Sci 99: 777-787.
129. TAKAHASHI, T., YAMAGUCHI, S., CHIDA, K. and SHIBYA, M. (2001). A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO 20: 2768-2778.
130. TAKASHIMA, S., KITAKAZE, M., ASAKURA, H., ASANUMA, H., SANADA, S., TASHIRO, F., NIWA, H., MIYAZAKI, J., HIROTA, S., KITAMURA, Y. et al. (2002). Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci USA 99: 3657-3662.
131. TAMMELA, T. and ALITALO, K. (2010). Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140: 460-476.
132. TAMMELA, T., ENHOLM, B., ALITALO, K. and PAAVONEN, K. (2005). The biology of vascular endothelial growth factors. Cardiovasc. Res. 65: 550-563.
133. TAYLOR, K.L., HENDERSON, A.M. and HUGHES, C.C. (2002). Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression. Microvasc Res 64: 372-383.
134. TONGERS, J., RONCALLI, J.G. and LOSORDO, D.W. (2010). Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res 79: 200-206.
135. TSE, C., XIANG, R.H., BRACHT, T. and NAYLOR, S.L. (2002). Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res. 62: 542-546.
136. UYTTENDAELE, H., HO, J., ROSSANT, J. and KITAJEWSKI, J. (2001). Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci USA 98: 5643-5648.
137. VALENZUELA, D.M., GRIFFITHS, J.A., ROJAS, J., ALDRICH, T.H., JONES, P.F., ZHOU, H., MCCLAIN, J., COPELAND, N.G., GILBERT, D.J., JENKINS, N.A. et al. (1999). Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA 96: 1904-1909.
138. VOKES, S.A., YATSKIEVYCH, T.A., HEIMARK, R.L., MCMAHON, J., MCMAHON, A.P., ANTIN, P.B. and KREIG, P.A. (2004). Hedgehog signaling is essential for endothelial tube formation during vasculogenesis. Development 131: 4371-4380.
139. WANG, B., XIAO, Y., DING, B.B., ZHANG, N., YUAN, X., GUI, L., QIAN, K.X., DUAN, S., CHEN, Z., RAO, Y. et al. (2003). Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 4: 19-29.
140. WANG, H.U., CHEN, Z.F. and ANDERSON, D.J. (1998). Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93: 741-753.
141. WANG, S., LI, X., PARRA, M., VERDIN, E., BASSEL-DUBY, R. and OLSON, E.N. (2008). Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. Proc Natl Acad Sci USA 105: 7738-7743.
142. WILSON, II B.D.M., PARK, K.W., SULI, A., SORENSEN, L.K., LARRIEU-LAHARGUE, F., URNESS, L.D., SUH, W., ASAI, J., KOCK, G.A. et al. (2006). Netrins promote developmental and therapeutic angiogenesis. Science 313: 640-644.
143. WOOLARD, J., WANG, W.Y., BEVAN, H.S., QIU, Y., MORBIDELLI, L., PRITCHARD-JONES, R.O., CUI, T.G., SUGIONO, M., WAINE, E., PERRIN, R. et al. (2004). VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 64: 7822-7835.
144. XIANG, R., DAVALOS, A.R., HENSEL, C.H., ZHOU, X.J., TSE, C. and NAYLOR, S.L. (2002). Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Cancer Res. 62: 2637-2643.
145. XUE, Y., GAO, X., LINDSELL, C.E., NORTON, C.R., CHANG, B., HICKS, C., GENDRON-MAGUIRE, M., RAND, E.B., WEINMASTER, G. and GRIDLEY, T. (1999). Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8: 723-730.
146. YAMAGUCHI, A., DUMONT, D.J., CONLON, R.A., BREITMAN, M.L. and ROSSANT, J. (1993). Flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118: 489-498.